UE LifeSciences Revenue and Competitors

Claim your profile



Total Funding

Estimated Revenue & Valuation

  • UE LifeSciences's estimated annual revenue is currently $8.2M per year.(i)
  • UE LifeSciences received $1.2M in venture funding in October 2016.
  • UE LifeSciences's estimated revenue per employee is $125,500
  • UE LifeSciences's total funding is $6.4M.

Employee Data

  • UE LifeSciences has 65 Employees.(i)
  • UE LifeSciences grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

UE LifeSciences (UELS) is leveraging innovative science and technology to enable cancer detection accessible and scalable in underserved populations globally. We're making this a reality with products such iBreastExam and NoTouch BreastScan in geographies across South Asia, South-East Asia, Middle East and Latin America. We're a growing team of Entrepreneurs, Engineers, Clinicians and Health Workers spread across offices in Philadelphia, Mumbai, Bangalore, Delhi and Kuala Lumpur.

keywords:Healthcare,Medical Diagnostics,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





UE LifeSciences News

2015-09-26 - UE LifeSciences Raises $3M in Series A Funding

UE LifeSciences, a Philadelphia, PA-based health technology developer, raised $3m in Series A funding. The round was led by Aarin Capital, with participation from Unitus Seed Fund. The company intends to use the capital to expand trials and setup manufacturing in India as well as to build dist ...

2015-09-14 - UE LifeSciences raises $3M from Aarin, Unitus

UE LifeSciences Inc, a health technology developer, has raised $3 million (Rs 20 crore) in its Series A round of funding led by Aarin Capital, a venture capital firm co-founded by Manipal Group’s Ranjan Pai and former Infosys director TV Mohandas Pai (not related). The company will use the mone ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

UE LifeSciences Funding

DateAmountRoundLead InvestorsReference
2015-09-15$3.0MAAarin CapitalArticle